Most common type of Chronic Aspergillosis Treatment is a long-term course of oral or inhaled medication
Chronic Aspergillosis Treatment An aspergillosis is a group of consuming diseases caused by Aspergillus fungus. Acute symptoms include coughing up sputum, weight loss, and fever. Patients with underlying pulmonary conditions or immunosuppression may have severe or fatal diseases. Although the prevalence of the disease is low, it is important to know that there are several treatments available for this disease. Diagnosis relies on Aspergillus precipitins, and thoracic computed tomography findings can include cavity formation, aspergilloma, or pneumonia. The global chronic aspergillosis treatment market is estimated to be valued at US$ 2,916.3 million in 2021 and is expected to exhibit a CAGR of 4.8 % during the forecast period (2021-2028). The hallmarks of CPA are new or expanding cavities, pericavitary fungal ball formation, and progressive destructive cavitary disease. The disease usually causes shortness of breath and blood cough. In severe cases, it can lead to significant scarr